References
- World Health Organisation. Global measles and rubella strategic plan 2012–2020 2012. http://www.unicef.org/immunization/files/Measles_Rubella_StrategicPlan_2012_2020.pdf
- De Serres G, Gay N, Farrington P. Epidemiology of transmissible diseases after elimination. Am J Epidemiol 2000; 151(11):1039-48; PMID:10873127; http://dx.doi.org/10.1093/oxfordjournals.aje.a010145
- Giddings G, Sibbald B. Imported measles outbreaks prompt call for parents to vaccinate their children. CMAJ 2014; 186(7):E205-6; http://dx.doi.org/10.1503/cmaj.109-4759
- Pegorie M, Shankar K, Welfare W, Wilson R, Khiroya C, Munslow G, Fiefield D, Bothra V, McCann R. Measles outbreak in Greater Manchester, England, October 2012 to September 2013: epidemiology and control. Euro Surveill 2014; 19(49); PMID:25523970
- Zipprich J, Winter K, Hacker J, Xia D, Watt J, Harriman K. Measles outbreak - California, December 2014-February 2015. MMWR - Morb Mortal Wkly Rep 2015; 64(6):153-4; PMID:25695321
- World Health Organisation. Progress in global measles control, 2000–2010. Wkly Epidemiol Rec 2012; 87(5):45-52; PMID:22308581
- Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mort Wkly Rep 2013; 62(RR04):1-34; PMID:23302815
- Ministry of Health. Immunisation Handbook 2014. Wellington: Ministry of Health; 2014. http://immunisation.book.health.govt.nz Accessed 21 June 2016
- CDNA. Measles: National guidelines for public health units. Canberra: Australian Government Department of Health; 2015
- Ramsay M, Manikkavasagan G, Brown K, Craig L. Post exposure prophylaxis for measles: revised guidance May 2009. UK: Health Protection Agency; 2009
- Young M, Cripps A. Passive immunization for the public health control of communicable diseases: current status in four high-income countries and where to next. Hum Vaccin Immunother 2013; 9(9):1885-93; PMID:23783220; http://dx.doi.org/10.4161/hv.25311
- Young M, Nimmo G, Cripps A, Jones M. Post-exposure passive immunisation for preventing measles. Cochrane Database Syst Rev 2014; (4):CD010056
- Viana P, Ono E, Miyamoto M, Salomao R, Costa-Carvalho B, Weckx L, et al. Humoral and cellular immune responses to measles and tetanus: the importance of elapsed time since last exposure and the nature of the antigen. J Clin Immunol 2010; 30:574-82; PMID:20405177; http://dx.doi.org/10.1007/s10875-010-9420-7
- Best, Voss, Roberts, Freeman. Measles - Infection Control Definitions & Guidelines Auckland, New Zealand: Auckland District Health Board; 2011 [updated October 2011]. http://www.adhb.govt.nz/starshipclinicalguidelines/_Documents/Measles.pdf
- Sinden J. Post exposure prophylaxis for measles New Zealand: NZBlood; 2012. http://www.nzblood.co.nz/assets/Transfusion-Medicine/PDFs/POST-EXPOSURE-PROPHYLAXIS-FOR-MEASLES-111G001.pdf
- CFR - Code of Federal Regulations Title 21, Food and Drugs, Section 640.104. Sect Volume 7 2011
- US Food and Drug Administration, Blood Products Advisory Committee. Meeting minutes August 16, 2007. Measles antibody levels in US immune globulin products. http://www.fda.gov/ohrms/dockets/ac/07/minutes/2007-4317M.htm Accessed September 28, 2015
- Immunisation Department. Measles. 2009. In: Immunoglobulin Handbook [Internet]. UK: Health Protection Agency. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1242198450982 (accessed October 9, 2012)
- European Pharmacopoeia. 8th ed. Strasbourg, France: European Department for the Quality of Medicines, Council of Europe; 2014
- Siennicka J, Czescik A, Trzcinska A. The significance for epidemiological studies anti-measles antibody detection examined by enzyme immunoassay (EIA) and plaque reduction neutralisation test (PRNT). Przegl Epidemiol 2014; 68:417-20; PMID:25394302
- Terletskaia-Ladwig E, Enders G, Meier S, Dietz K, Enders M. Development and evaluation of an automatable focus reduction neutralisation test for the detection of measles virus antibodies using imaging analysis. J Virol Methods 2011; 178:124-8; PMID:21939689; http://dx.doi.org/10.1016/j.jviromet.2011.08.026
- Reynolds G, Dias C, Thornley S, King R, Morrison A, Matson A, Hoskins R. Analysis of the Auckland 2014 measles outbreak indicates that adolescents and young adults could benefit from catch-up vaccination. N Z Med J 2015; 128(1422):53-62
- Minister for Health Tony Ryall. Measles outbreak prompts vaccination push [Media Statement]: New Zealand Governement; August 6 2009. https://www.beehive.govt.nz/release/measles-outbreak-prompts-vaccination-push (accessed June 1, 2016)
- Grifols Therapeutics Inc. Immune Globulin (Human): GamaSTAN S/D 2013. http://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/FractionatedPlasmaProducts/UCM371376.pdf
- Endo A, Izumi H, Miyashita M, Taniguchi K, Okubo O, Harada K. Current efficacy of postexposure prophylaxis against measles with immunoglobulin. J Pediatr 2001; 138:926-8; PMID:11391343; http://dx.doi.org/10.1067/mpd.2001.113710
- Cohen B, Audet S, Andrews N, Beeler J. Plaque neutralization test for measles antibodies: description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination. Vaccine 2007; 21(1):59-66; http://dx.doi.org/10.1016/j.vaccine.2007.10.046